U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07165301) titled 'Postprandial Distress Itopride Cohort Trial' on Aug. 20.
Brief Summary: Functional Dyspepsia (FD) is a common gastrointestinal disorder affecting about 7.2% of the population, characterized by gastroduodenal symptoms without an identifiable organic cause. It is divided into two subtypes based on the Rome IV criteria: (i) Postprandial Distress Syndrome (PDS): Meal-related symptoms like postprandial fullness and early satiation.; (ii) Epigastric Pain Syndrome (EPS): Meal-unrelated symptoms like epigastric pain or burning.
Treatment options are limited, but prokinetics are commonly used, targeting suspected motility issues. A meta-an...